drugset / Trial / NCT01389102

Estradiol Transdermal Spray in the Treatment of Vasomotor Symptoms

NCT01389102

Phase 3 Completed 454 enrolled Lumara Health, Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

Estradiol treatment is effective at reducing vasomotor symptoms (eg hot flushes) in postmenopausal women. This study will evaluate the safety and efficacy of Evamist.

Timeline

Start
2004-12
Primary completion
2006-11
Completion
2006-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Estradiol Other / unclassified 1.53 mg Other
Comparator Estradiol Other / unclassified 3.06 mg Other
Comparator Estradiol Other / unclassified 4.59 mg Other

Indications

No indication recorded.